North America Digital Health Ecosystem 2023 Mid Year Report

Don’t miss the North America H1 2023 Key Trends in Digital Health with this semi-annual report on the current state and future outlook of the global Digital Health ecosystem. The past year’s macro events are accelerating the sector’s maturity and driving consolidation of this highly fragmented industry.

While this contraction signifies progress towards a stronger and more relevant future, addressing the hype surrounding Digital Health is crucial. Recent incidents like Babylon’s collapse and Pear Therapeutics’ bankruptcy serve as cautionary tales, emphasizing the need for substantiated proof points, realistic projections, and tangible results. The North America H1 2023 Key Trends report focuses on private ventures and includes current trends, ecosystem development, most active partners, and venture funding.

  • Venture funding in North America returned to pre-pandemic levels at $8.25B, falling 41% compared to the H1 2022 values to reach only $8.28B, but funding is up 13% from the H2 2022 values and remained nearly constant from Q1 to Q2.
  • North America captured 69% of all announced Digital Health partnerships in the first half of 2023. Despite the downturn in funding, the first half of 2023 has seen a 1.2x growth in partnerships compared to same period in 2022.
  • Medical Diagnostics and Patient Solutions capture together 40% of the ventures with an Evidence Signal (ES) greater than 40. Across all Digital Health Clusters, 19% of all N. American ventures have significant clinical evidence.
  • Ventures with products that focus on Neurology moved from the 4th place spot for funding value in 2022 into the top spot in H1 2023. Increasing by 15% over H2 2022, funding in the Neurology reached $901M in H1 2023. 26% of the 2023 funding was raised in Series A funding rounds.

The “North America Digital Health Innovation Ecosystem Report on H1 2023 Key Trends” report includes data on the following companies: Pear Therapeutics, Lucira Health, Babylon Health, Femtec Health, Pomelo Care, Finni Health, Caraway, BenchSci, Little Journey, and others

HealthTech Alpha, a Galen Growth proprietary solution, powers this report!

About our Premium Reports

Our Premium Reports are specialized reports that are only available to active users with HealthTech Alpha Pro and HealthTech Alpha Enterprise accounts and are provided at no additional cost.

Source of Data

Galen Growth’s proprietary platform, HealthTech Alpha, provides the data source for this report. Corporate Business Development, Business Intelligence, and Digital Health Partnership teams worldwide prefer HealthTech Alpha, the world’s most-trusted Digital Health data, intel, and insights platform. Visit to learn more about our data or research for our reports.

Our Mission

Founded in 2016 by Digital Health experts, Galen Growth empowers global Fortune 500 companies, institutional investors, and promising Digital Health ventures to fast track their digital health strategy to create significant financial and social values. To find out more, visit

HEADLINES: 9 pages, 6 charts, 4 tables
ECOSYSTEM INSIGHTS: 5 pages, 7 charts, 2 tables
INVESTMENT INSIGHTS: 6 pages, 6 charts, 1 table
CLUSTER FOCUS: 4 pages, 2 charts, 1 table
THERAPEUTIC FOCUS: 3 pages, 2 charts, 1 table
DEEP DIVES: 21 pages, 24 charts, 4 tables
NOTEWORTHY: 4 pages, 3 tables

Buy Only


  • Purchase and download this report
  • Access to limited data in HealthTech Alpha
Buy Now


  • Sign up now to download all premium research
  • Access and download all data in HealthTech Alpha
$ 385 /Month
Custom Solution


  • Get full access to unmatched premium research for your organization
  • Additional collaboration features to take your team's research and collaboration to the next level
Let's Talk
Contact Us

© Galen Growth 2024




Total Funding

GGA Score

powered by